Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 10
Submit an article Journal homepage
1,255
Views
47
CrossRef citations to date
0
Altmetric
Original Research

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

Michaela SemeraroGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Julien AdamDepartment of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France;Module de Développement en Pathologie Expérimentale-INSERM U981, Gustave-Roussy Cancer Campus, Villejuif, France
,
Gautier StollGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Emilie LouvetModule de Développement en Pathologie Expérimentale-INSERM U981, Gustave-Roussy Cancer Campus, Villejuif, France
,
Kariman ChabaGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Vichnou Poirier-ColameFaculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France;Department of Immuno-Oncology, Gustave Roussy Cancer Campus, Villejuif, France
,
Allan SauvatGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Laura SenovillaGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Erika VacchelliGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Norma BloyGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France
,
Juliette HumeauGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France
,
Aitziber BuqueGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Oliver KeppGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Laurence ZitvogelFaculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France;Department of Immuno-Oncology, Gustave Roussy Cancer Campus, Villejuif, France;INSERM, U1015, Villejuif, France
,
Fabrice AndréINSERM, U981 “Identification of molecular predictors and new targets for cancer treatment”, Villejuif, France;Department of Medical Oncology and Breast Cancer Group, Gustave Roussy Cancer Campus, Villejuif, France
,
Marie-Christine MathieuDepartment of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France
,
Suzette DelalogeDepartment of Medical Oncology and Breast Cancer Group, Gustave Roussy Cancer Campus, Villejuif, France
&
Guido KroemerGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1138, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
 show all
Article: e1218106 | Received 11 Jul 2016, Accepted 22 Jul 2016, Published online: 11 Oct 2016

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Jonathan Pol, Juliette Paillet, Céleste Plantureux & Guido Kroemer. (2022) Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases. OncoImmunology 11:1.
Read now
Fei-Fei Xu, Sai-Fang Zheng, Cheng Xu, Gang Cai, Shu-Bei Wang, Wei-Xiang Qi, Chao-Fu Wang, Jia-Yi Chen & Cao Lu. (2021) Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ. OncoImmunology 10:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 9:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Gautier Stoll, Margerie Kremer, Normal Bloy, Adrien Joseph, Maria Castedo, Guillaume Meurice, Christophe Klein, Lorenzo Galluzzi, Judith Michels & Guido Kroemer. (2019) Metabolic enzymes expressed by cancer cells impact the immune infiltrate. OncoImmunology 8:6.
Read now
Kristina Iribarren, Aitziber Buque, Laura Mondragon, Wei Xie, Sarah Lévesque, Jonathan Pol, Laurence Zitvogel, Oliver Kepp & Guido Kroemer. (2019) Anticancer effects of anti-CD47 immunotherapy in vivo. OncoImmunology 8:3.
Read now
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, Bertrand Routy, Aurélie Fluckiger, Takahiro Yamazaki, Kristina Iribarren, Connie P. M. Duong, Laetitia Fend, Anne Caignard, Isabelle Cremer, Axel LeCesne, Julien Adam, Charles Honoré, Olivier Mir, Loïc Chaigneau, Anne Berger, Pierre Validire, Christos Christidis, Valérie Le Brun-Ly, Mark J. Smyth, Xavier Mariette, Benoît L. Salomon, Guido Kroemer, Sylvie Rusakiewicz & Laurence Zitvogel. (2018) TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. OncoImmunology 7:12.
Read now
Gautier Stoll, Jonathan Pol, Vassili Soumelis, Laurence Zitvogel & Guido Kroemer. (2018) Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts. OncoImmunology 7:10.
Read now
Gautier Stoll, Yuting Ma, Heng Yang, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2017) Pro-necrotic molecules impact local immunosurveillance in human breast cancer. OncoImmunology 6:4.
Read now

Articles from other publishers (38)

Noriko Goda, Shinsuke Sasada, Hideo Shigematsu, Norio Masumoto, Koji Arihiro, Hiroyoshi Nishikawa, Shimon Sakaguchi, Morihito Okada & Takayuki Kadoya. (2022) The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer. Discover Oncology 13:1.
Crossref
Lyndsey S. Crump, Kelsey T. Kines, Jennifer K. Richer & Traci R. Lyons. (2022) Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis. American Journal of Physiology-Cell Physiology 323:5, pages C1475-C1495.
Crossref
Mathilde M. Almekinders, Tycho Bismeijer, Tapsi Kumar, Fei Yang, Bram Thijssen, Rianne van der Linden, Charlotte van Rooijen, Shiva Vonk, Baohua Sun, Edwin R. Parra Cuentas, Ignacio I. Wistuba, Savitri Krishnamurthy, Lindy L. Visser, Iris M. Seignette, Ingrid Hofland, Joyce Sanders, Annegien Broeks, Jason K. Love, Brian Menegaz, Lodewyk Wessels, Alastair M. Thompson, Karin E. de Visser, Erik Hooijberg, Esther Lips, Andrew Futreal, Jelle Wesseling, Esther Lips, Jelle Wesseling, Lodewyk Wessels, Andrew Futreal & Alastair M. Thompson. (2022) Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk. British Journal of Cancer 127:7, pages 1201-1213.
Crossref
Léa Montégut, Rafael de Cabo, Laurence Zitvogel & Guido Kroemer. (2022) Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer. Cancer Discovery 12:10, pages 2258-2279.
Crossref
Faranak Sobhani, Sathya Muralidhar, Azam Hamidinekoo, Allison H. Hall, Lorraine M. King, Jeffrey R. Marks, Carlo Maley, Hugo M. Horlings, E. Shelley Hwang & Yinyin Yuan. (2022) Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ. npj Breast Cancer 8:1.
Crossref
Farbod Darvishian, Yinxiang Wu, Ugur Ozerdem, Jennifer Chun, Sylvia Adams, Amber Guth, Deborah Axelrod, Richard Shapiro, Andrea B. Troxel, Freya Schnabel & Daniel Roses. (2022) Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ. The Breast 64, pages 35-40.
Crossref
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, Helena Olofsson, Amanda Lindberg, Erik Holmberg, Troy Bremer, Patrick Micke, Per Karlsson, Fredrik Wärnberg & Carina Strell. (2022) Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial. European Journal of Cancer 168, pages 128-137.
Crossref
Julia Solek, Jedrzej Chrzanowski, Adrianna Cieslak, Aleksandra Zielinska, Dominika Piasecka, Marcin Braun, Rafal Sadej & Hanna M. Romanska. (2022) Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2. Biomedicines 10:5, pages 1061.
Crossref
Aleida Núñez-Ruiz, Flor Sánchez-Brena, Cynthia López-Pacheco, Naray A. Acevedo-Domínguez & Gloria Soldevila. (2022) Obesity modulates the immune macroenvironment associated with breast cancer development. PLOS ONE 17:4, pages e0266827.
Crossref
Noriko Goda, Chika Nakashima, Ichiro Nagamine & Sunao Otagaki. (2022) The Effect of Intratumoral Interrelation among FOXP3+ Regulatory T Cells on Treatment Response and Survival in Triple-Negative Breast Cancer. Cancers 14:9, pages 2138.
Crossref
Gemma M. Wilson, Phuong Dinh, Nirmala Pathmanathan & J. Dinny Graham. (2022) Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression. Journal of Mammary Gland Biology and Neoplasia 27:1, pages 101-131.
Crossref
Nanna Jørgensen, Thomas Vauvert F. Hviid, Lise B. Nielsen, Ida M. H. Sønderstrup, Jens Ole Eriksen, Bent Ejlertsen, Anne-Marie Gerdes, Torben A. Kruse, Mads Thomassen, Maj-Britt Jensen & Anne-Vibeke Lænkholm. (2021) Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British Journal of Cancer 125:10, pages 1388-1398.
Crossref
Rafael Caparica, Marco Bruzzone, Elisa Agostinetto, Maria Alice Franzoi, Marcello Ceppi, Nina Radosevic-Robin, Frédérique Penault-Llorca, Karen Willard-Gallo, Sherene Loi, Roberto Salgado & Evandro de Azambuja. (2021) Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis. The Breast 59, pages 183-192.
Crossref
Laurence Zitvogel, Claude Perreault, Olivera J. Finn & Guido Kroemer. (2021) Beneficial autoimmunity improves cancer prognosis. Nature Reviews Clinical Oncology 18:9, pages 591-602.
Crossref
Marie Colombe Agahozo, Marcel Smid, Ronald van Marion, Dora Hammerl, Thierry P. P. van den Bosch, Mieke A. M. Timmermans, Chayenne J. Heijerman, Pieter J. Westenend, Reno Debets, John W. M. Martens & Carolien H. M. van Deurzen. (2021) Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells. Biology 10:8, pages 768.
Crossref
Haruna Yagi, Masato Nakaguro, Masafumi Ito, Yuki Okumura, Seishiro Takahashi, Yoichiro Aoshima, Yasunori Enomoto, Shiori Meguro, Hideya Kawasaki, Isao Kosugi, Yoshie Shimoyama, Hiroshi Ogawa, Hisashi Tateyama & Toshihide Iwashita. (2021) Difference in the distribution of tumor‐infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma. Pathology International 71:7, pages 453-462.
Crossref
Kellsye P Fabian, Michelle R Padget, Rika Fujii, Jeffrey Schlom & James W Hodge. (2021) Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve. Journal for ImmunoTherapy of Cancer 9:2, pages e001691.
Crossref
Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh & Nima Rezaei. (2020) Immune microenvironment in different molecular subtypes of ductal breast carcinoma. Breast Cancer Research and Treatment 185:2, pages 261-279.
Crossref
Milim Kim, Yul Ri Chung, Hyun Jeong Kim, Ji Won Woo, Soomin Ahn & So Yeon Park. (2020) Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Research 22:1.
Crossref
Jie Wang, Shu Tian, Ji Sun, Jiahao Zhang, Lan Lin & Chunyan Hu. (2020) The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma. BMC Cancer 20:1.
Crossref
Qi Wu, Ai-Ling Tian, Sylvère Durand, Fanny Aprahamian, Nitharsshini Nirmalathasan, Wei Xie, Peng Liu, Liwei Zhao, Shuai Zhang, Hui Pan, Didac Carmona-Gutierrez, Frank Madeo, Yi Tu, Oliver Kepp & Guido Kroemer. (2020) Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy. Cell Death & Disease 11:11.
Crossref
Miglena Komforti, Sunil S Badve, Bryan Harmon, Yungtai Lo & Susan Fineberg. (2020) Tumour‐infiltrating lymphocytes in ductal carcinoma in situ (DCIS)—assessment with three different methodologies and correlation with Oncotype DX DCIS Score . Histopathology.
Crossref
Luis Alberto Solis-Castillo, Gina Stella Garcia-Romo, Alvaro Diaz-Rodriguez, Diana Reyes-Hernandez, Elizabeth Tellez-Rivera, Victor Hugo Rosales-Garcia, Adolfo Rene Mendez-Cruz, Jose Rafael Jimenez-Flores, Victor Hugo Villafana-Vazquez & Alexander Pedroza-Gonzalez. (2020) Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer. Breast Cancer 27:5, pages 837-849.
Crossref
Pedro Marques, Ashley B. Grossman & Márta Korbonits. (2020) The tumour microenvironment of pituitary neuroendocrine tumours. Frontiers in Neuroendocrinology 58, pages 100852.
Crossref
Aye Aye Thike, Xiaoyang Chen, Valerie Cui Yun Koh, Nur Diyana Binte Md Nasir, Joe P S Yeong, Boon Huat Bay & Puay Hoon Tan. (2020) Higher densities of tumour‐infiltrating lymphocytes and CD4 + T cells predict recurrence and progression of ductal carcinoma in situ of the breast . Histopathology 76:6, pages 852-864.
Crossref
Marie Colombe Agahozo, Mieke R. van Bockstal, Floris H. Groenendijk, Thierry P. P. van den Bosch, Pieter J. Westenend & Carolien H. M. van Deurzen. (2019) Ductal carcinoma in situ of the breast: immune cell composition according to subtype. Modern Pathology 33:2, pages 196-205.
Crossref
Pedro Marques, Sayka Barry, Eivind Carlsen, David Collier, Amy Ronaldson, Sherine Awad, Neil Dorward, Joan Grieve, Nigel Mendoza, Samiul Muquit, Ashley B. Grossman, Frances Balkwill & Márta Korbonits. (2019) Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours. Acta Neuropathologica Communications 7:1.
Crossref
Farbod Darvishian, Ugur Ozerdem, Sylvia Adams, Jennifer Chun, Elizabeth Pirraglia, Elianna Kaplowitz, Amber Guth, Deborah Axelrod, Richard Shapiro, Alison Price, Andrea Troxel, Freya Schnabel & Daniel Roses. (2019) Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS). Annals of Surgical Oncology 26:10, pages 3337-3343.
Crossref
Xiao-Yang Chen, Joe Yeong, Aye Aye Thike, Boon Huat Bay & Puay Hoon Tan. (2019) Prognostic role of immune infiltrates in breast ductal carcinoma in situ. Breast Cancer Research and Treatment 177:1, pages 17-27.
Crossref
M. Messaoudene, T.P. Mourikis, J. Michels, Y. Fu, M. Bonvalet, M. Lacroix-Trikki, B. Routy, A. Fluckiger, S. Rusakiewicz, M.P. Roberti, S. Cotteret, C. Flament, V. Poirier-Colame, N. Jacquelot, F. Ghiringhelli, A. Caignard, A.M.M. Eggermont, G. Kroemer, A. Marabelle, M. Arnedos, C. Vicier, S. Dogan, F. Jaulin, S -J Sammut, W. Cope, C. Caldas, S. Delaloge, N. McGranahan, F. André & L. Zitvogel. (2019) T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants. Annals of Oncology 30:6, pages 934-944.
Crossref
Yuichiro Miyoshi, Tadahiko Shien, Akiko Ogiya, Naoko Ishida, Kieko Yamazaki, Rie Horii, Yoshiya Horimoto, Norikazu Masuda, Hiroyuki Yasojima, Touko Inao, Tomofumi Osako, Masato Takahashi, Nobumoto Tomioka, Yumi Wanifuchi‑Endo, Mitsuchika Hosoda, Hiroyoshi Doihara & Hiroko Yamashita. (2018) Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer. Oncology Letters.
Crossref
Claire Lhuillier, Claire Vanpouille-Box, Lorenzo Galluzzi, Silvia Chiara Formenti & Sandra Demaria. (2018) Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in Cancer Biology 52, pages 125-134.
Crossref
Marie Colombe Agahozo, Dora Hammerl, Reno Debets, Marleen Kok & Carolien H M van Deurzen. (2018) Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?. Modern Pathology 31:7, pages 1012-1025.
Crossref
Artur Mezheyeuski, Christian Holst Bergsland, Max Backman, Dijana Djureinovic, Tobias Sjöblom, Jarle Bruun & Patrick Micke. (2018) Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. The Journal of Pathology 244:4, pages 421-431.
Crossref
Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael Dallas, Dawson Knoblock, Jean D. Boyer, Jian Yan, Russell Vang, Amir S. Khan, Laurent Humeau, Niranjan Y. Sardesai, J. Joseph Kim, Stanley Plotkin, David B. Weiner, Cornelia L. Trimble & Mark L. Bagarazzi. (2018) Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy. Clinical Cancer Research 24:2, pages 276-294.
Crossref
Cinzia Solinas, Soizic Garaud, Pushpamali De Silva, Anaïs Boisson, Gert Van den Eynden, Alexandre de Wind, Paolo Risso, Joel Rodrigues Vitória, François Richard, Edoardo Migliori, Grégory Noël, Hugues Duvillier, Ligia Craciun, Isabelle Veys, Ahmad Awada, Vincent Detours, Denis Larsimont, Martine Piccart-Gebhart & Karen Willard-Gallo. (2017) Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Frontiers in Immunology 8.
Crossref
Carlos R. Gil Del Alcazar, Sung Jin Huh, Muhammad B. Ekram, Anne Trinh, Lin L. Liu, Francisco Beca, Xiaoyuan Zi, Minsuk Kwak, Helga Bergholtz, Ying Su, Lina Ding, Hege G. Russnes, Andrea L. Richardson, Kirsten Babski, Elizabeth Min Hui Kim, Charles H. McDonnellIIIIII, Jon Wagner, Ron Rowberry, Gordon J. Freeman, Deborah Dillon, Therese Sorlie, Lisa M. Coussens, Judy E. Garber, Rong Fan, Kristie Bobolis, D. Craig Allred, Joon Jeong, So Yeon Park, Franziska Michor & Kornelia Polyak. (2017) Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition . Cancer Discovery 7:10, pages 1098-1115.
Crossref
Gloria Romagnoli, Meike Wiedermann, Friederike Hübner, Antonia Wenners, Micaela Mathiak, Christoph Röcken, Nicolai Maass, Wolfram Klapper & Ibrahim Alkatout. (2017) Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. International Journal of Molecular Sciences 18:9, pages 1936.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.